A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia

被引:303
作者
Vase, L
Riley, JL
Price, DD
机构
[1] Univ Florida, Hlth Sci Ctr, Dept Oral & Maxillofacial Surg, Gainesville, FL 32610 USA
[2] Univ Florida, Hlth Sci Ctr, Dept Neurosci, Gainesville, FL 32610 USA
[3] Univ Aarhus, Dept Psychol, DK-8240 Risskov, Denmark
[4] Univ Florida, Coll Dent, Div Publ Hlth Serv & Res, Gainesville, FL 32610 USA
关键词
placebo analgesia; magnitude; instruction; conditioning; suggestion;
D O I
10.1016/S0304-3959(02)00205-1
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A previous meta-analysis of clinical analgesic trial studies showed generally low magnitudes of placebo analgesia (N. Engl. J. Med. 344 (2001) 1594). However, as studies included in their analysis used only placebo as a control condition, we conducted two meta-analyses, one in which 23 studies used only placebo as a control condition, and one in which 14 studies investigated placebo analgesic mechanisms. Magnitudes of placebo analgesic effects were much higher in the latter (mean effect size = 0.95) as compared to the former (mean effect size = 0.15) and were significantly different (P = 0.003). This difference as well as differences in effect sizes within studies of placebo mechanisms may be parsimoniously explained by differences in expected pain levels produced by placebo suggestions and by conditioning. Furthermore, some of the studies of placebo analgesic mechanisms indicate that the magnitude of placebo analgesia is higher when the placebo analgesic effect is induced via suggestion combined with conditioning than via suggestion alone or conditioning alone. Based on these findings, we suggest that placebo analgesic effects are most optimally conceptualized in terms of perception of the placebo agent, and therefore a new definition of placebo response is proposed. (C) 2002 International Association for the Study of Pain. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:443 / 452
页数:10
相关论文
共 63 条
[1]   Response variability to analgesics: a role for non-specific activation of endogenous opioids [J].
Amanzio, M ;
Pollo, A ;
Maggi, G ;
Benedetti, F .
PAIN, 2001, 90 (03) :205-215
[2]   Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems [J].
Amanzio, M ;
Benedetti, F .
JOURNAL OF NEUROSCIENCE, 1999, 19 (01) :484-494
[3]   PREVENTION OF BREAST PAIN AND MILK SECRETION WITH BROMOCRIPTINE AFTER SECOND-TRIMESTER ABORTION [J].
Andersen, Anders Nyboe ;
Damm, Peter ;
Tabor, Ann ;
Pedersen, Inger Maria ;
Harring, Mette .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1990, 69 (03) :235-238
[4]  
[Anonymous], 1985, PLACEBO THEORY RES M
[5]   INCREASED STRESS AND EFFECTIVENESS OF PLACEBOS AND ACTIVE DRUGS [J].
BEECHER, HK .
SCIENCE, 1960, 132 (3419) :91-92
[6]   THE POWERFUL PLACEBO [J].
BEECHER, HK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1955, 159 (17) :1602-1606
[7]   Control of postoperative pain by transcutaneous electrical nerve stimulation after thoracic operations [J].
Benedetti, F ;
Amanzio, M ;
Casadio, C ;
Cavallo, A ;
Cianci, R ;
Giobbe, R ;
Mancuso, M ;
Ruffini, E ;
Maggi, G .
ANNALS OF THORACIC SURGERY, 1997, 63 (03) :773-776
[8]  
Benedetti F, 1999, J NEUROSCI, V19, P3639
[9]   The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia [J].
Benedetti, F .
PAIN, 1996, 64 (03) :535-543
[10]   POTENTIATION OF PLACEBO ANALGESIA BY PROGLUMIDE [J].
BENEDETTI, F ;
AMANZIO, M ;
MAGGI, G .
LANCET, 1995, 346 (8984) :1231-1231